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of Large Granular Lymphocytes
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Infection in a Human
Immunodeficiency Virus–Infected
Patient Receiving Antiretroviral
Therapy
Andreas Kronenberg,1 Jo¨rg D. Seebach,2 Walter Bossart,3
and Rainer Weber1
1Division of Infectious Diseases and Hospital Epidemiology
and 2Laboratory for Transplantation Immunology, Department of Internal
Medicine, University Hospital of Zu¨rich, and 3Institute of Clinical Virology,
University of Zu¨rich
We report the first case of a patient infected with HIV in
whom polyclonal CD8+/CD57 T lymphocyte large granular
lymphocyte (LGL) proliferation was observed in association
with cytomegalovirus primary infection. Because the differ-
ential diagnosis of an increased number of LGLs includes
both monoclonal LGL leukemia and polyclonal proliferation
of LGL, patients in whom LGL proliferation is detected al-
ways need close hematological and clinical observation to
determine whether therapeutic intervention is necessary.
In HIV-infected individuals who are receiving potent antire-
troviral therapy, opportunistic infections may manifest atypi-
cally. Here we describe the case of a patient who presented with
clinical and hematological features strongly resembling malig-
nant lymphoma while suffering from acute cytomegalovirus
(CMV) infection.
Case report. A 33-year-old HIV-positive homosexual man
presented with fever and mild symptoms that included head-
ache, arthralgias, malaise, night sweats, cough, and diarrhea
that had lasted for 3 weeks. His medical history included Can-
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dida stomatitis, amoebiasis with liver abscess, intestinal Giardia
lamblia infection, and recurrent perianal condylomata accu-
minata. Oral anticoagulant therapy had been initiated 6 years
earlier following vena cava thrombosis and pulmonary em-
bolisms that were associated with elevated levels of plasminogen
activator inhibitor and antiphospholipid antibodies. He had
been receiving antiretroviral therapy for 10 years. His current
medication included stavudine, lamivudine, nelfinavir, and
efavirenz.
The patient’s HIV-1 RNA load was 340 copies/mL. One
month before the onset of the acute illness, the total peripheral
blood lymphocyte count was 2004 cells/mL (CD4, 575 cells/
mL [29% of total lymphocytes]; and CD8, 697 cells/mL [34%];
CD4:CD8 ratio, 0.8). A physical examination revealed a body
temperature of 37.8C, but other clinical findings were unre-
markable. A computer scan of the thorax and abdomen ap-
peared normal except for mild splenomegaly (length of sagittal
axis, 16 cm). The patient’s LDH level was 858 U/L, and CRP
level was 26 mg/L. The prothrombin time was prolonged while
he was receiving anticoagulant therapy (international normal-
ized ratio, 1.5), but serum levels of electrolytes and markers of
liver and kidney function were in the normal range. The WBC
count was 9390 cells/mL, and the lymphocyte count was 5420
cells/mL (57.7% of WBC count). The thrombocyte count was
139,000 cells/mL, and the hematocrit was in the normal range.
A scattergram produced by an automatic cell counter (AD-
VIA120; Bayer Switzerland) revealed lymphocytosis and ele-
vated levels of large unknown cells (LUC; 2440 cells/mL; 23.8%
of WBCs; figure 1A); therefore, microscopic examination of a
peripheral blood smear was performed. It revealed that 33%
of the patient’s lymphocytes were LGL (figure 1 B). Immu-
nophenotypical analysis of peripheral blood mononuclear cells
(PBMC) by means of flow cytometry revealed that a majority
of CD3/TCRab T cells (77.2% of PMBC) coexpressed CD8
(3319 cells/mL; 47.9% of PMBC), whereas only a minority of
the cells expressed CD4 (603 cells/mL; 8.7% of PMBC), CD57
(6.3% of PMBC), or natural killer (NK) cell markers, including
CD16 (8.2% of PMBC) and CD56 (11.0% of PMBC). This
corresponded to markedly reduced CD4:CD8 ratio of 0.2.
Furthermore, the activation markers CD25 (12.5% of PMBC)
and CD69 (19.3% of PMBC) were present on a subset of PBMC.
Clonal T cell proliferation was ruled out by the results of a
Southern blot analysis of the TCR rearrangement in PBMC,
and a bone marrow biopsy specimen did not show evidence
of infiltrative lymphoma. Serological analysis revealed serocon-
version, with newly detectable anti-CMV IgM and IgG anti-
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Figure 1. Automated and microscopic WBC counts and differential counts for an HIV-positive patient with an increase in the number of large
granular lymphocytes (LGL) in response to cytomegalovirus infection. A, Scattergram of WBC generated by an automated hemocytometer by cell size
(Y-axis) and peroxidase activity (X-axis). The increase in the number of large unknown cells (LUC) in the upper left field indicates the presence of
LGL. B, Pappenheim-stained blood smear of WBC concentrate with several LGL compared with normal neutrophils. The inset shows the typical
morphology of large granular lymphocytes, which are characterized by a large, irregular shaped nucleus and azurophilic granules (original magnification,
400; inset, 1000).
bodies. Levels of CMV-specific antibodies were determined by
use of commercial ELISA systems (IgG: VIDAS, bioMe´rieux;
IgM: MEDAC). Antibody titers, which were determined in 4
consecutive serum samples obtained during a period of roughly
6 months, were as follows: for IgG, 0, 18, 30, and 48 arbitrary
units/mL; and for IgM, indexes (i.e., signal over background
ratio) of 0.1, 14.1, 6.8, and 0.9.
CMV was isolated from shell-vial cultures of specimens of
MRC-5 human fibroblasts and was confirmed by means of
immunofluorescence assay (monoclonal antibody MicroTrak;
Behring) and PCR (with use of primers and PCR protocol as
described in [1]). No evidence was found of other acute bac-
terial or viral infections, including herpes simplex virus 1 and
2, Epstein-Barr virus, and human herpesvirus 6 or human her-
pesvirus 8.
Lymphocytosis and elevated LUC levels normalized without
specific therapy in !1 week, and the patient became asymp-
tomatic during the following weeks. After 1 year of follow-up,
slightly elevated CD8 counts of 1000–1200 cells/mL were
found, which were associated with CD4 counts of 600–750/
mL. At that time, 54.5% of the patient’s CD8 cells (554 cells/
mL) coexpressed the CD57 marker.
Discussion. LGL are a morphologically recognizable subset
of lymphocytes, comprising 10%–15% of normal PBMC. Dif-
ferential diagnosis of an increased number of LGL includes
monoclonal LGL leukemia and polyclonal proliferation of LGL
[2, 3]. Monoclonal LGL leukemia is thought to develop from
an initially antigen-driven specific response and is further di-
vided into 2 phenotypical subgroups. (1) The first of these is
the more common CD3 T-LGL leukemia, which manifests as
a chronic disorder associated with the following: systemic
symptoms, such as fever, night sweats, and/or weight loss; sple-
nohepatomegaly; autoimmune diseases, such as rheumatoid ar-
thritis; and neutropenia, which is likely to be induced by soluble
Fas ligand molecules and can lead to recurrent bacterial infec-
tions. (2) The second phenotypical subgroup is the rare but
clinically more aggressive CD3 NK-LGL leukemia. In contrast
to frank leukemia, polyclonal LGL proliferations are usually
benign and self-limited. They occur in patients with a variety
of clinical disorders, including solid tumors, idiopathic throm-
bocytopenic purpura, Hodgkin’s and non-Hodgkin’s lym-
phoma, and viral infections. Overall, the finding of elevated
numbers of LGL in a blood smear, even in the absence of
peripheral blood lymphocytosis [4], warrants further diagnostic
evaluation for the presence of LGL leukemia or the underlying
cause of LGL proliferation.
In our patient, CD8/CD57 LGL proliferation was associ-
ated with both long-standing HIV infection and acute CMV
infection, both of which may have been responsible for the
observed proliferation. The CD8 coreceptor recognizes MHC
class I molecules and is associated with cytotoxic T lympho-
cytes, proliferation of which is induced by viral infections. In
contrast, much less is known about the function and signifi-
cance of the CD57 glycoprotein, which can be expressed by
subsets of both NK cells and T cells. Only recently, the coex-
pression by CD8 T cells of CD57, which are found in a variety
of diseases including viral infections, has become a focus of
interest [5] . It has been shown that CMV infection can induce
a self-limited increase of CD8/CD57 granular T cells in im-
munocompetent hosts. A rapid increase of CD8/CD57 T cells
was also observed during the first week of CMV infection in
solid organ transplant recipients who were receiving immu-
nosuppressive therapy [6]. In a majority (12 of 16) of these
patients the absolute number of CD8 T cells remained elevated
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for4 years, with a progressive replacement of the initial poly-
clonal CD8/CD57 T lymphocytes by CD8/CD57 cells [6].
Other studies have described 3 patients with monoclonal pro-
liferations of CD8/CD57 T LGLs after kidney transplantation
in the absence of ongoing active CMV infection or any other
viral disease [7, 8]. Two of these patients had suffered from
acute CMV infection early after transplantation, suggesting a
transformation from CMV-induced polyclonal to monoclonal
proliferation of CD8/CD57 T lymphocytes [7]. All 3 patients
had a clinically indolent course, which is in sharp contrast to
the course of posttransplantation lymphoproliferative disease
caused by CD8/CD56/CD57 T-LGL leukemia [8].
CMV infection or reactivation frequently occurs during the
first 3 months after allogenic bone marrow transplantation and
leads to a strong polyclonal stimulation of CD8/CD57 T cells.
This immunological response, which occurs during immuno-
suppressive therapy, provides protection from CMV disease
and, interestingly, seems to be associated with both graft-versus-
leukemia activity and a low incidence of relapse of leukemia
in recipients of T cell–depleted bone marrow [9].
On the other hand, early HIV infection may induce an increase
in the number of CD8 T cells. Rarely, CD8 lymphocytosis
syndrome may develop, or a diffuse infiltrative lymphocytosis
syndrome, which is characterized by the sequestration of CD8
T cells in the salivary glands, lungs, kidneys, and other visceral
sites [10]. The absolute increase of CD8 lymphocytes is
thought to represent an immune response to HIV-related an-
tigens, and it has been demonstrated that these CD8 T cells
have functional activity against HIV.
Smith et al. [10] found that lymphoproliferation was mono-
clonal in 5 out of 18 patients with CD8 lymphocytosis who
were examined. Nevertheless, the clinical course was benign,
indicating that the change to monoclonal lymphoproliferation
is not necessarily associated with clinical malignancy. Moreover,
proliferation of morphologically atypical CD8 lymphocytes
has been described in cases of acute coinfection with HIV and
CMV [11, 12]. However, in most of these cases, the CD57
phenotype, TCR rearrangement, and the presence or absence
of LGL were not determined [12]. Only 2 cases of benign LGL
proliferation have been described in HIV-infected patients:
CD3/CD8 NK-LGL proliferation in one [13], and mono-
clonal CD3/CD8/CD57 T-LGL proliferation in the other
[14]. It is not clear whether these cases of proliferation were
associated with CMV infection because CMV detection by
means of antigen-detection or positive PCR results was not
performed.
Because LGL proliferation was not present in our patient
prior to CMV-infection, we strongly believe that the polyclonal
proliferation of CD8/CD57 T LGL was induced by acute
CMV infection and not by preexisting HIV infection. Although
there was no further treatment, the proliferation had a benign,
self-limited clinical course characterized by the emergence of
a CD8/CD57 population. However, patients in whom LGL
proliferation is detected always need close hematological and
clinical observation to determine whether therapeutic inter-
vention is necessary.
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